Recent Progress in Gonadal Dysgenesis

Paul G McDonough

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Molecular biology is revolutionizing reproductive medicine. The conceptual, diagnostic, and therapeutic advances in the management of individuals with gonadal dysgenesis have been driven largely by technical advances in molecular biology, cardiac imaging, assisted reproduction, and the production of recombinant proteins. Significant amount of basic information has been obtained which is relevant to somatic differentiation of the gonad, X-chromosome inactivation, and putative growth genes. Major technological advances in high-resolution and 3-D ultrasonography, magnetic resonance imaging (MRI), and operative laparoscopy provide new resources to assist in diagnosis and management of patients with gonadal dysgenesis. Techniques like, DNA amplification and fluorescence in situ hybridization (FISH) has added broader dimensions to detect somatic mosaicism and for the clarification of X-Y structural alterations. Patients who are at risk for aortic dissection are identified using serial echocardiography for aortic diameter. With recent advances, techniques of assisted reproduction using sibling and anonymous egg donors have made gestational motherhood a reality for carefully selected patients with gonadal dysgenesis.

Original languageEnglish (US)
Title of host publicationDiagnosis and Management of Ovarian Disorders
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages51-59
Number of pages9
ISBN (Print)9780120536429
DOIs
StatePublished - Jan 1 2003

Fingerprint

Gonadal Dysgenesis
Molecular biology
Laparoscopy
Ultrasonography
Imaging techniques
Echocardiography
Dissection
Molecular Biology
Magnetic resonance
Chromosomes
Recombinant Proteins
Nucleic Acid Amplification Techniques
Medicine
Reproductive Techniques
Reproductive Medicine
Amplification
X Chromosome Inactivation
Mosaicism
Genes
Fluorescence

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

McDonough, P. G. (2003). Recent Progress in Gonadal Dysgenesis. In Diagnosis and Management of Ovarian Disorders: Second Edition (pp. 51-59). Elsevier Inc.. https://doi.org/10.1016/B978-012053642-9/50008-9

Recent Progress in Gonadal Dysgenesis. / McDonough, Paul G.

Diagnosis and Management of Ovarian Disorders: Second Edition. Elsevier Inc., 2003. p. 51-59.

Research output: Chapter in Book/Report/Conference proceedingChapter

McDonough, PG 2003, Recent Progress in Gonadal Dysgenesis. in Diagnosis and Management of Ovarian Disorders: Second Edition. Elsevier Inc., pp. 51-59. https://doi.org/10.1016/B978-012053642-9/50008-9
McDonough PG. Recent Progress in Gonadal Dysgenesis. In Diagnosis and Management of Ovarian Disorders: Second Edition. Elsevier Inc. 2003. p. 51-59 https://doi.org/10.1016/B978-012053642-9/50008-9
McDonough, Paul G. / Recent Progress in Gonadal Dysgenesis. Diagnosis and Management of Ovarian Disorders: Second Edition. Elsevier Inc., 2003. pp. 51-59
@inbook{34547fe5d12b4a87a142f27a02db3878,
title = "Recent Progress in Gonadal Dysgenesis",
abstract = "Molecular biology is revolutionizing reproductive medicine. The conceptual, diagnostic, and therapeutic advances in the management of individuals with gonadal dysgenesis have been driven largely by technical advances in molecular biology, cardiac imaging, assisted reproduction, and the production of recombinant proteins. Significant amount of basic information has been obtained which is relevant to somatic differentiation of the gonad, X-chromosome inactivation, and putative growth genes. Major technological advances in high-resolution and 3-D ultrasonography, magnetic resonance imaging (MRI), and operative laparoscopy provide new resources to assist in diagnosis and management of patients with gonadal dysgenesis. Techniques like, DNA amplification and fluorescence in situ hybridization (FISH) has added broader dimensions to detect somatic mosaicism and for the clarification of X-Y structural alterations. Patients who are at risk for aortic dissection are identified using serial echocardiography for aortic diameter. With recent advances, techniques of assisted reproduction using sibling and anonymous egg donors have made gestational motherhood a reality for carefully selected patients with gonadal dysgenesis.",
author = "McDonough, {Paul G}",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/B978-012053642-9/50008-9",
language = "English (US)",
isbn = "9780120536429",
pages = "51--59",
booktitle = "Diagnosis and Management of Ovarian Disorders",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Recent Progress in Gonadal Dysgenesis

AU - McDonough, Paul G

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Molecular biology is revolutionizing reproductive medicine. The conceptual, diagnostic, and therapeutic advances in the management of individuals with gonadal dysgenesis have been driven largely by technical advances in molecular biology, cardiac imaging, assisted reproduction, and the production of recombinant proteins. Significant amount of basic information has been obtained which is relevant to somatic differentiation of the gonad, X-chromosome inactivation, and putative growth genes. Major technological advances in high-resolution and 3-D ultrasonography, magnetic resonance imaging (MRI), and operative laparoscopy provide new resources to assist in diagnosis and management of patients with gonadal dysgenesis. Techniques like, DNA amplification and fluorescence in situ hybridization (FISH) has added broader dimensions to detect somatic mosaicism and for the clarification of X-Y structural alterations. Patients who are at risk for aortic dissection are identified using serial echocardiography for aortic diameter. With recent advances, techniques of assisted reproduction using sibling and anonymous egg donors have made gestational motherhood a reality for carefully selected patients with gonadal dysgenesis.

AB - Molecular biology is revolutionizing reproductive medicine. The conceptual, diagnostic, and therapeutic advances in the management of individuals with gonadal dysgenesis have been driven largely by technical advances in molecular biology, cardiac imaging, assisted reproduction, and the production of recombinant proteins. Significant amount of basic information has been obtained which is relevant to somatic differentiation of the gonad, X-chromosome inactivation, and putative growth genes. Major technological advances in high-resolution and 3-D ultrasonography, magnetic resonance imaging (MRI), and operative laparoscopy provide new resources to assist in diagnosis and management of patients with gonadal dysgenesis. Techniques like, DNA amplification and fluorescence in situ hybridization (FISH) has added broader dimensions to detect somatic mosaicism and for the clarification of X-Y structural alterations. Patients who are at risk for aortic dissection are identified using serial echocardiography for aortic diameter. With recent advances, techniques of assisted reproduction using sibling and anonymous egg donors have made gestational motherhood a reality for carefully selected patients with gonadal dysgenesis.

UR - http://www.scopus.com/inward/record.url?scp=84902218676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902218676&partnerID=8YFLogxK

U2 - 10.1016/B978-012053642-9/50008-9

DO - 10.1016/B978-012053642-9/50008-9

M3 - Chapter

AN - SCOPUS:84902218676

SN - 9780120536429

SP - 51

EP - 59

BT - Diagnosis and Management of Ovarian Disorders

PB - Elsevier Inc.

ER -